|
Basic clinical data |
|||
| CHD patients (n = 93) |
Control group (n = 49) |
p |
|
|
|
|||
| Age (years)(median, 25th percentile/75th percentile) |
63, 57/69 |
64, 58/73 |
0,43 |
| Men (%) |
56,99 |
42,86 |
0,11 |
| Hypertension (%) |
79,78 |
10,20 |
0,0000 |
| Diabetes (%) |
37,08 |
0 |
- |
| Stable angina (%) |
100 |
- |
|
| Smokers (%) |
|||
| Current Ex-smokers Non-smokers |
15,19 56,96 27,85 |
10,53 39,47 50,00 |
0,03 |
| NYHA, median, interquartile range |
0, 0–1 |
- |
- |
| CCS, median, interquartile range |
2, 2–3 |
- |
- |
| EuroSCORE, median, interquartile range |
3, 1–4 |
- |
- |
| Medicines (%) |
|||
| β-blockers |
80,85 |
6 |
0,0000 |
| Statins |
82,98 |
0 |
- |
| Ca – blockers |
18,08 |
4 |
0,45 |
| Nitrates |
55,32 |
2 |
0,0000 |
| Diuretics |
23,40 |
2 |
0,07 |
| Spironolacton |
6,38 |
0 |
- |
| Insulin |
14,89 |
0 |
- |
| Oral anti-diabetics |
22,34 |
0 |
- |
| ASA |
91,49 |
0 |
- |
| Digoxin |
0 |
0 |
- |
| ACE inhibitors |
72,34 |
0 |
- |
|
The results are shown as median, 25th percentile/75th percentile. | |||
Hak et al. Immunity & Ageing 2007 4:3 doi:10.1186/1742-4933-4-3 |
|||